Dermatology NewsNew influx of Humira biosimilars may not drive immediate changeFebruary 22, 2023Autoimmune DiseasesPsoriasisPsoriatic ArthritisBusiness of Medicine
Dermatology NewsNew tool better estimates cardiovascular risk in people with lupusFebruary 16, 2023Autoimmune Diseases
Dermatology NewsHealth plans get very poor scores for access to autoimmune drugsFebruary 14, 2023Business of MedicinePsoriatic ArthritisPsoriasisAutoimmune Diseases
Dermatology NewsTopical CBD oil study suggests benefits for pain, healing in systemic sclerosis digital ulcersJanuary 25, 2023Autoimmune Diseases
Dermatology NewsBest estimates made for hydroxychloroquine retinopathy riskJanuary 18, 2023Autoimmune DiseasesInfectious Diseases
Dermatology NewsBelimumab for pregnant women with lupus: B-cell concerns remainJanuary 17, 2023Autoimmune Diseases
Rituximab Treatment and Improvement of Health-Related Quality of Life in Patients With PemphigusJanuary 3, 2023Autoimmune Diseases
Dermatology NewsCombination therapy shows mixed results for scleroderma-related lung diseaseNovember 15, 2022Rare DiseasesAutoimmune Diseases
Dermatology NewsLower hydroxychloroquine dose for lupus tied to hospitalizations for flaresNovember 14, 2022Autoimmune Diseases
Dermatology NewsFirst recommendations for cancer screening in myositis issuedNovember 12, 2022Autoimmune DiseasesRare Diseases
Atypical Localized Scleroderma Development During Nivolumab Therapy for Metastatic Lung AdenocarcinomaOctober 20, 2022Nonmelanoma Skin CancerAutoimmune Diseases
Dermatology NewsDermatologists fear effects of Dobbs decision for patients on isotretinoin, methotrexateOctober 14, 2022AcnePsoriasisAtopic DermatitisAutoimmune DiseasesMixed TopicsHealth Policy
Dermatology NewsIVIG proves effective for dermatomyositis in phase 3 trialOctober 11, 2022Autoimmune DiseasesRare Diseases
